No insider purchase over the last 90 days. The latest, by 임찬양, was filed 29 Jun 2026.
Noul Co.,Ltd.: what insiders have been doing
Every trade that managers of Noul Co.,Ltd. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 5 November 2026, 38 filings were filed, from 12 insiders.
The record shows 14 purchases on the open market worth €283k, made by 9 insiders, against 20 sales worth €196k by 6 insiders. No amount is published for 31 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a sale of €196k by Mseed,Inc., published on 15 May 2026, equal to 1.3% of the market capitalisation. Those buying include 7 board members, 1 major shareholder and 1 chief executive.
Within a 30-day window, 2 purchases overlapped with buying by a second insider. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 29 June 2026, 134 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 2 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
For context, the typical company on the same exchange (median of 2,656 companies) published 7 filings over the same period, against 38 filings here. The full history, which starts in 2022, counts 24 purchases against 22 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySale+5 other insiders
Since the insiders bought
- -64.9%Entry ₩1,654 · Close at T+90 ₩581
- -64.9%Entry ₩1,654 · Close at T+90 ₩581
- -2.1%Entry ₩2,120 · Close at T+365 ₩2,075
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 1,000,000 sharesShareKRXDART:20260729000431
- ●Executives0DART
- 1,392,327 sharesShareKRXDART:20260629000559Canonical exit: 27 Sept 2026 (T+90)
- 20,000 sharesKRXDART:20260629000540Canonical exit: 27 Sept 2026 (T+90)
- ●Executives0DART
- 1,392,327 sharesShareKRXDART:20260629000550Canonical exit: 27 Sept 2026 (T+90)
- 10,000 sharesShareKRXDART:20260622000101Canonical exit: 20 Sept 2026 (T+90)
- 200,000 sharesShareKRXDART:20260612000536
- 200,000 sharesShareKRXDART:20260612000526
- 1,000,000 sharesShareKRXDART:20260612000546
- ●Executives0DART
- 10,000 sharesShareKRXDART:20260522000042Canonical exit: 20 Aug 2026 (T+90)
- 300,000 shares1.31% mcap100.0% of flowKRXDART:20260515002608
- 300,000 sharesShareKRXDART:20260515002308
25 of 99 declarations
About Noul Co.,Ltd.
노을 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance patient health.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
